FACELE: Impact of Training Patient-centered Approach on Shared Decision in Colorectal Cancer Screening

Sponsor
CNGE Conseil (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06074536
Collaborator
(none)
400
2
19.9

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the effect of face-to-face training of general practitioners on the implementation of a shared decision (in the context of colorectal cancer screening), versus current practice (i.e. without training in the patient-centered approach).

Condition or Disease Intervention/Treatment Phase
  • Procedure: patient-centered approach training
N/A

Detailed Description

Colorectal cancer (CRC) affects 95% of cases of people aged over 50 years old with an average age of diagnosis of 71 years for men and 73 years for women with a higher prevalence in women. By the age of 75, 4 out of 100 men and 3 out of 100 women will have developed colorectal cancer.

In France, CRC screening is based on a guaiac faecal occult blood test in subjects at risk average, carried out every 2 years from 50 to 74 years old. In the event of a positive test, a colonoscopy should be performed. Participation in the programme colorectal cancer screening has been declining since 2016-2017.

The implementation of screening faces many barriers on the physian's side and/or on the patient's side. During of the last 2020-2021 screening campaign, only 6.1 million people took a screening test, which represented a participation rate of 28.9%, while it is commonly admitted that a screening rate >50% would be necessary to reduce CRC mortality.

Some barriers are specific to CRC screening. for patient, reluctance to carry out screening, analysis of stools, and fear of cancer. For the physian, the discomfort in approaching screening and the uncertainty of the relevance of the test for some patients. The know-how and quality of information and communication with patients is at the forefront.

Physian must adapt their communication to the possibilities understanding of the subject to explain, convince, and bring the patient to carry out screening. Active listening is a technique particularly suitable for adopting a person-centred approach making it possible to take into account the patient perspectives in order to arrive at a shared decision.

This most often involves helping and giving the patient the means to manage their problems, involving them in a prevention project (non-requesting patient) or supporting them and motivating them in their approach (requesting patient).

The hypothesize of this study is that training general practitioners in a patient-centered approach will enable the implementation of greater shared decision-making work with the patient during a CRC screening presentation consultation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patient-centered face-to-face training for General Practitioners on implementation of a shared decisionPatient-centered face-to-face training for General Practitioners on implementation of a shared decision
Masking:
Single (Participant)
Masking Description:
Patient not informed of the randomization arm to which their general practitioner enrolled
Primary Purpose:
Prevention
Official Title:
Impact of Training in the Patient-centered Approach on Shared Decision-making in the Colorectal Cancer Screening: a Cluster Randomized Trial
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Aug 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interventional arm

The recruited GPs will be randomized into 2 parallel groups (interventional and control). Following this randomization, the GPs from the interventional group will undergo face-to-face training to the patient-centered approach.

Procedure: patient-centered approach training
face to face training of general practitioner of interventional arm

No Intervention: Control arm

The GPs of the control group will take care the patient according to current screening recommendations and procedures organized by the colorectal cancer (CCR) mass screening.

Outcome Measures

Primary Outcome Measures

  1. The Measurement of the achievement oh the shared decision shared decision making in CRC screening using the patient shared a self-decision-making questionnaire (SDM-Q9), validated in French [6 to 8 months after after patient nclusion (carrying out the screening test)]

    comparison of the mean of the SDM-Q9 between each arm of the study from 0 (weak shared decision) to 100 (strong shared decision). We will compare the average of the SDM-Q9 between each arm of the study

Secondary Outcome Measures

  1. Evaluate the effect of training on the CRC screening rate [Measurements taken 6 months after the last patient was included in the trial, i.e. no later than 18 months after the start of the trial]

    participation rate in organized CRC screening at individual level. Measurements taken 6 months after the last patient was included in the trial,

  2. Confronting the shared decision made by the patient regarding the completion of CRC screening [Measurements taken 6 months after the last patient was included in the trial, i.e. no later than 18 months after the start of the trial]

    Participation rate (IC95%) in CRC screening according to the patient's decision at the end of the initial consultation: wish to be screened, neutral, wish not to be screened.

  3. Explore understanding of the shared decision process among general practitioners and patients [Data collected immediately after the inclusion visit]

    Proportion (IC95%) of included patients with a SURE test result of less than 4

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 74 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient aged 50 to 74:

  • Eligible for organized CRC screening,

  • Having declared as attending clinician a general practitioner investigator of the study

✓ Consulting their attending clinician for the duration of the study,

  • AND able and willing to comply with all trial requirements
Exclusion Criteria:
  • ✓ Screened for CRC less than 2 years ago

  • Not eligible for organized CRC screening:

  • History of adenomas or CRC:

  • Family (1st degree)

  • Personal history of IBD:

  • Crohn's disease

  • Ulcerative colitis)

  • Hereditary predispositions:

  • Familial adenomatous polyposis

  • Hereditary non-polyposis colorectal cancer (Lynch syndrome)

  • Having a level of literacy that does not allow the completion of the self-questionnaire.

  • Having an inability to give express consent.

  • Being under guardianship, curatorship or having cognitive disorders

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • CNGE Conseil

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CNGE Conseil
ClinicalTrials.gov Identifier:
NCT06074536
Other Study ID Numbers:
  • CNGE-2021-04
  • IDRCB:2023-A00859-36
First Posted:
Oct 10, 2023
Last Update Posted:
Oct 10, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2023